Abstract:ObjectiveTo find novel potential gene mutations other than EXT1 and EXT2 mutations, to expand the mutational spectrum of EXT and to explore the correlation between clinical outcome and genotype in patients with hereditary multiple exostoses (HME).MethodsThe study recruited seven families diagnosed with multiple osteochondromas (MO). Family histories and clinical information were collected in detail through comprehensive physical and image examination. Patients with deformities and functional limitations were classified as “severe” and the remaining without functional limitations were classified as “mild,” in accordance with previous study. Whole‐exome sequencing (WES) was performed on a total of 13 affected individuals, 1 available unaffected relative, and 10 healthy unrelated individuals. Sanger sequencing was used to validate the screened mutations. Finally, the structural change in protein caused by pathogenic mutations was analyzed using information from the relevant database online and we attempted to correlate clinical phenotype with genotype in patients with HME.ResultsOther than EXT1 and EXT2, no novel potential gene mutations were found through WES. We identified nine heterozygous mutations in EXT1 or EXT2. Of these mutations, four have not been reported previously. These are c.996delT in exon 2 of EXT1 (family 1), c.544C > T in exon 3 of EXT2 (family 2), c.1171C > T in exon 7 of EXT2 (family 5), and c.823–824delAA in exon 5 of EXT1 (family 7). The other five mutations have already been reported in previous works. It was surprising that we found two mutation sites, in exon 2 and exon 5, respectively, of EXT1 in 1 patient diagnosed with MO, when his father had two mutation sites, in exon 6 and exon 5, respectively, of EXT1 and EXT2 (family 4). In addition, 1 patient showed degeneration, while his father only exhibited slight symptoms (family 7). In our study, among 51 affected patients in seven families, the sex ratio (male vs female) was 58.9% (n = 30) vs 41.2% (n = 21). Male patients seemed to show more severe symptoms compared to females, but because the sample was small, we did not obtain statistically significance results.ConclusionWhole‐exome sequencing to screen pathogenic gene mutations was applied successfully. Although no third‐gene mutation associated with HME was found, a total of nine mutations across EXT1 and EXT2 were identified, four of which are novel. Our results expand the mutational spectrum of EXT and can be used in genetic counseling and prenatal diagnosis for patients with MO.

Study on EXT Gene Mutation of a Pedigree with Hereditary Multiple Exostoses

Identification of a Novel EXT1 Mutation in a Pedigree Affected with Hereditary Multiple Exostosis

[Mutation Analysis of EXT2 Gene in a Family with Hereditary Multiple Exostosis].

Identification of four novel EXT1 and EXT2 mutations in five Chinese pedigrees with hereditary multiple exostoses.

[A New EXT2 Mutation in a Chinese Family with Hereditary Multiple Exostoses].

Clinical phenotype and mutation analysis of EXT1 and EXT2 genes in one hereditary multiple exostosis family

NEW MUTATIONS IN EXT1 AND EXT2 IN CHINESE FAMILIES WITH HEREDITARY MULTIPLE EXOSTOSES

Gene Mutation Screening and the Genotype-Phenotype Correlation of Hereditary Multiple Exostoses

Identification of a Novel EXT1 Mutation in Patients with Hereditary Multiple Exostosis by Exome Sequencing

A Splice Mutation and Mrna Decay of EXT2 Provoke Hereditary Multiple Exostoses

Identification of a Novel EXT2 Frameshift Mutation in a Family with Hereditary Multiple Exostoses by Whole-Exome Sequencing.

Novel Mutations of EXT1 and EXT2 Genes among Families and Sporadic Cases with Multiple Exostoses.

[Mutation analysis of EXT genes in two pedigrees with hereditary multiple exostoses].

Identification of Novel EXT Mutations in Patients with Hereditary Multiple Exostoses Using Whole‐Exome Sequencing

Identification Of Pathogenic Mutations In 6 Chinese Families With Multiple Exostoses By Whole-Exome Sequencing And Multiplex Ligation-Dependent Probe Amplification Case Series

A Mutation IVS2+1G>A in EXT2 Gene Causes Hereditary Multiple Exostoses

A Novel Mutation In Ext2 Caused Hereditary Multiple Exostoses Through Reducing The Synthesis Of Heparan Sulfate

[A Mutation 1633-26(C-->A) in EXT1 Gene Causes Multiple Exostoses].

Mutation Analysis of Hereditary Multiple Exostoses in the Chinese.

[Identification of Mutations in the Human EXT1 and EXT2 Genes].

A Novel Splice Mutation Induces Exon Skipping of the EXT1 Gene in Patients with Hereditary Multiple Exostoses